These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1730512)

  • 1. Analysis of regulation of T-cell responses by soluble inhibitory factors from the sera of patients with Hodgkin's disease.
    Damle RN; Advani SH; Gangal SG
    Int J Cancer; 1992 Jan; 50(2):192-6. PubMed ID: 1730512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA; Hill RB; Heldman L; Ramakrishnan S
    Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.
    Miossec P; Elhamiani M; Edmonds-Alt X; Sany J; Hirn M
    Arthritis Rheum; 1990 Nov; 33(11):1688-94. PubMed ID: 2242065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue.
    Kurane I; Innis BL; Nimmannitya S; Nisalak A; Meager A; Janus J; Ennis FA
    J Clin Invest; 1991 Nov; 88(5):1473-80. PubMed ID: 1939640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of soluble IL-2 receptor in the serum and bone marrow of patients with minimal residual hematological malignancies: induction under therapy with IL-2.
    Kandefer-Szerszeń M; Legieć W; Dmoszyńska A; Rzeski W
    Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):443-8. PubMed ID: 9437500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-2 regulation of soluble IL-2 receptor levels following thermal injury.
    Teodorczyk-Injeyan JA; Sparkes BG; Lalani S; Peters WJ; Mills GB
    Clin Exp Immunol; 1992 Oct; 90(1):36-42. PubMed ID: 1382903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted expression of mitogen-induced high affinity IL-2 receptors in aging mice.
    Proust JJ; Kittur DS; Buchholz MA; Nordin AA
    J Immunol; 1988 Dec; 141(12):4209-16. PubMed ID: 3264308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte activation and cytokine production in autoimmune hemolytic anaemia (AIHA).
    Fagiolo E; Abenante L
    Autoimmunity; 1996; 24(3):147-56. PubMed ID: 9020407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2.
    Ammar A; Sahraoui Y; Tsapis A; Bertoli AM; Jasmin C; Georgoulias V
    J Clin Invest; 1992 Jul; 90(1):8-14. PubMed ID: 1321845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased soluble interleukin-2 receptor concentration in plasma predicts a decreased cellular response to IL-2.
    Gooding R; Riches P; Dadian G; Moore J; Gore M
    Br J Cancer; 1995 Aug; 72(2):452-5. PubMed ID: 7640231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo?
    Dummer R; Posseckert G; Nestle F; Witzgall R; Burger M; Becker JC; Schäfer E; Wiede J; Sebald W; Burg G
    J Invest Dermatol; 1992 Jan; 98(1):50-4. PubMed ID: 1728640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells.
    de la Calle-Martín O; Alberola-Ila J; Engel P; Inglés J; Fabregat V; Barceló JJ; Lozano F; Gallart T
    Eur J Immunol; 1992 Apr; 22(4):897-902. PubMed ID: 1551406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired CD25 expression and soluble CD25-IL-2R alpha receptor release by anti-CD3 stimulated peripheral blood mononuclear cells in Hodgkin's disease patients.
    Frydecka I; Mazur G
    Arch Immunol Ther Exp (Warsz); 1996; 44(2-3):127-30. PubMed ID: 8915517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma.
    Gause A; Roschansky V; Tschiersch A; Smith K; Hasenclever D; Schmits R; Diehl V; Pfreundschuh M
    Ann Oncol; 1991 Feb; 2 Suppl 2():43-7. PubMed ID: 2049320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptors abrogate IL-2 induced activation of peripheral mononuclear cells.
    Zorn U; Dallmann I; Grosse J; Kirchner H; Poliwoda H; Atzpodien J
    Cytokine; 1994 Jul; 6(4):358-64. PubMed ID: 7948742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains.
    Dummer R; Posseckert G; Sugamura K; Grundmann H; Burg G
    J Interferon Cytokine Res; 1996 Apr; 16(4):315-20. PubMed ID: 9162525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
    Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
    J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-2 receptor in vitro production by mononuclear cells from Hodgkin patients.
    Caruso C; Modica MA; Candore G; Di Giulio C; Galluzzo A; Giordano C; Di Marco P; Gebbia V; Tamone Reyes M; Citarrella P
    Boll Ist Sieroter Milan; 1990; 69(1):335-8. PubMed ID: 2102116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.